国: 台湾
言語: 中国語
ソース: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)
STREPTOCOCCUS PYROGENE SU STRAIN TX WITH PN G POTASSIUM
台灣中外製藥股份有限公司 台北市松山區敦化北路260號3樓 (23060795)
L01XX
凍晶注射劑
STREPTOCOCCUS PYROGENE SU STRAIN TX WITH PN G POTASSIUM (5608001231) (1.4MG)MG
小瓶
製 劑
限由醫師使用
UKIMA PLANT OF CHUGAI PHARMA MANUFACTURING CO., LTD. 5-1, UKIMA 5-CHOME, KITA-KU, TOKYO JAPAN JP
Other antineoplastic agents
消化器癌(胃癌、肝臟癌、膽道癌、大腸癌)頭頸部癌(上顎癌、喉、咽頭癌、舌癌)甲狀腺癌、肺癌
註銷日期: 2019/05/28; 註銷理由: 自請註銷; 有效日期: 2023/04/20; 英文品名: PICIBANIL 0.5KE
已註銷
2017-10-25
1 2 Benzylpenicillin Potassium ® 0.2 KE 0.5 KE 1 KE 5 KE • 1 mg 0.56 1.4 2.8 14 mg 0.02 0.2 KE 0.05 0.5 KE 0.1 1 KE 0.5 5 KE Magnesium sulfate hydrate mg 0.02 0.05 0.10 0.48 DL-Methionine mg 0.04 0.10 0.20 1.00 Maltose hydrate mg 17.69 17.23 8.37 1.34 Benzylpenicilline potassium 540 1,350 2,690 13,470 Monobasic potassium phosphate Sodium hydroxide Sodium chloride • ~ pH 2 6.0 ~ 7.5 2 1 1 Lyophilized powder containing the cells of Streptococcus pyogenes Su strain A group type 3 treated with benzylpenicillin Potassium 2 • 6.0 ® 0.2 KE PICIBANIL ® 0.2 KE 019928 ® 0.5 KE PICIBANIL ® 0.5 KE 019927 ® 1 KE PICIBANIL ® 1 KE 019923 ® 5 KE PICIBANIL ® 5 KE 019924 1 2~3 0.2~1 KE 2~3 1~3 KE KE 2 ml 5% 2 1 5-10 KE 2 ml 1 3 1 5-10 KE 2 ml 2~3 4 0.2~0.5 KE 1 3~5 1~5 KE 1~3 KE 2 ml 2 1. 1 2 Cephem 3 2. 1 1 2 3 4 2 3. 26,027 8,312 31.9% 13,092 6,019 23.1% 2,893 11.1% 1,198 4.6% 848 3.3% 789 3.0% 1982 3 352 333 94.6% 1,049 303 86.1% 279 79.3% 210 59.7% CRP 80 22.7% WBC 64 18.2% 18 5.1% 2008 10 1 1 2 X 3 BUN 2 ≥ 5% < 5% 3 4 5 6 3 GOT GPT ALP BUN 7 CRP 8 CK CPK 3 4 79.3% 5 59.7% 6 18.2% 7 23.1% 86.1% 8 22.7% 4. 5. 6. 1 2 ml 2 1 2 a. b. 3 1 2 3 7. 1~ 1. 1 1 46 0.2 KE 4 2 KE 2 KE 1 % 100 80 60 40 20 1 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 p < 0.01 2 311 0.2 KE 2 KE 2 KE 2 2 73 0.2 KE 2 KE 2 KE 3 n=159 n=152 % 100 80 60 40 20 2 0 6 12 18 24 30 36 42 48 54 60 p < 0.05 2. 1 134 76 56.7% 8 6.0% 4 2 25 17 68.0% 6 24.0% 5 3. 6 52 10 5 KE 2~3 10 KE 52 17.3% 10 20.0% 4. 7 0.5 KE/10 ml 1.0 KE/10 ml 20 ml 2 53 75.5% 6 48 85.4% 1. 1 8 methylcholanthorene 9 2 10 11 12 3 13 L1210 fluorouracil 2. 1 14 2 15 16 15 NK 17 CTL 18 IL-1 IL-2 19 IL-8 20 IL-12 21 IFN-r 22 TNF- α 20 G-CSF 20 GM-CSF 20 3 23,24 TNF 10 C 2 100 1 3 4 : 715 1976 2 Watanabe, Y. et al J. Biol. Response Mod 6 2 : 169 1987 3 38 4 : 405 1985 4 Torisu, M. et al. Surgery 93 3 : 357 1983 5 6 5 : 1161 1979 6 32 S-6 : 455 1989 7 31 1 : 29 1995 8 1969 9 1975 10 Biotherapy 4 2 : 155 1990 11 2 6 : 985 1975 12 17 5 : 1284 1982 13 Koshimura, S. et al. Cancer Treat Rep. 61 1 : 完全なドキュメントを読む